Ann Gils

5PUBLICATIONS
11CO-AUTHORS
Work integrated learning (incl. internships)Gene and molecular therapyPharmaceutical delivery technologiesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Feb 24, 2026
Motivational factors for general practice training and career establishment: A cross-sectional study in Flanders, Belgium.

Lotta E Coenen, Madieke Maseman, Janique Lobbestael

|Aug 18, 2019
Achieving Mucosal Healing in Inflammatory Bowel Diseases: Which Drug Concentrations Need to Be Targeted?

Nathalie Van den Berghe, Ann Gils, Debby Thomas

|Apr 21, 2019
Clinical response correlates with 4-week postinjection ustekinumab concentrations in patients with moderate-to-severe psoriasis.

N Van den Berghe, E De Keyser, R Soenen

|Oct 16, 2018
Letter: overcoming secondary loss of response to infliximab-it is not the drug, it is how you use it! Authors' reply.

Erwin Dreesen, Ann Gils

|Dec 12, 2017
Anti-infliximab antibody concentrations can guide treatment intensification in patients with Crohn's disease who lose clinical response.

E Dreesen, T Van Stappen, V Ballet

Pageof 1

Frequent Collaborators

2 joint publications

Nathalie Van den Berghe

1 joint publications

M Ferrante

1 joint publications

R Soenen

1 joint publications

S Lanssens